The overall prevalence of opiate use has been increasing, currently affecting approximately
0.6% of the global population and resulting in a significant proportion of infants being born …

The opioid epidemic in the United States has resulted in a significant increase in opioid use
disorder among pregnant women and a concomitant increase in the incidence of neonatal …

Aim This systematic review aims to estimate the relationship between prenatal exposure to
opioids and neurodevelopmental outcomes and examines potential sources of …

This chapter focuses on the myriad of factors that are known or suspected to cause
neurodevelopmental alterations in children to show the challenge with drawing a clear …

The rates of opioid use disorder during pregnancy have more than quadrupled in the last
decade, resulting in numerous infants suffering exposure to opioids during the perinatal …

Neonatal opioid withdrawal syndrome (NOWS) has risen in prevalence from 1.2 per 1000
births in 2000 to 5.8 per 1000 births in 2012. Symptoms in neonates may include high …

Prenatal opioid exposure adversely impacts upon fetal growth and places the newborn at
risk of neonatal opioid withdrawal. The severity and duration of opioid withdrawal cannot be …

The opioid epidemic has adversely affected neonates and children, yet the mechanisms by
which it impacts this population are not well understood. Not only does prenatal opioid …

Background Prenatal opioid exposure has been linked to adverse birth outcomes and
delays in infant development. Existing literature is limited by a simple group-differences …

Prenatal opioid exposure has reached epidemic proportions. In the last 10 years, there has
been a 242% increase in the number of babies born with the drug withdrawal syndrome …